ReviewFrontiers in pharmacology2024

Endothelin receptor antagonists (ERAs) can potentially be used as therapeutic drugs to reduce hypertension caused by small molecule tyrosine kinase inhibitors (TKIs).

Qingjian He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.